The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare

Abstract

The misuse of prescription opioids has become a serious epidemic in the US. In response, states have implemented Prescription Drug Monitoring Programs (PDMPs), which record a patient's opioid prescribing history. While few providers participated in early systems, states have recently begun to require providers to access the PDMP under certain circumstances. We find that "must access" PDMPs significantly reduce measures of misuse in Medicare Part D. In contrast, we find that PDMPs without such provisions have no effect. We find stronger effects when providers are required to access the PDMP under broad circumstances, not only when they are suspicious.

Medical cannabis legalization and opioid prescriptions: evidence on US Medicaid enrollees during 1993–2014

“…The non‐significant findings were also reported in some previous studies , but not all . The research using most recent data sources, however, consistently suggested the program effectiveness in states that adopted best practices .…”

The effect of evictions on accidental drug and alcohol mortality

“…We also included a set of variables that reflect the availability of health care services, and so access to prescription drugs: percent of the county population with no health insurance; and the number of active Medical Doctors per 1000 population. Since past research has indicated that state‐level “must‐access” electronic prescription drug monitoring programs have statistically significant effects on opioid use, we also include an indicator variable for that state policy . Finally, all models include year indicator variables and county fixed effects.…”

Prescription Opioids and Labor Market Pains

“…Previous research has shown that adverse labor market conditions may contribute to higher disability rates (Black et al, 2002;Autor and Duggan, 2003;Erceg and Levin, 2014;Hall, 2015). Similarly, as chronic diagnosed pain is by itself grounds for disability, the direction of causation between opioid use and disability may run in either direction (GAO, 2011;Morden et al, 2014;Meara et al, 2016;Buchmueller and Carey, 2017;Song, 2017). 27…”